← Browse by Condition
Medical Condition

gout

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 3, Phase 4

ClinicalMetric tracks all active clinical trials for gout sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — gout Clinical Trials

How many clinical trials are currently recruiting for gout?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for gout, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for gout?
gout research spans Phase 3 (2 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a gout clinical trial?
Eligibility criteria for gout trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
2
Phase 4
1
Top Sponsors
Crystalys Therapeutics 1 trial
Lille Catholic University 1 trial
Assistance Publique - Hôpitaux de Paris 1 trial
Seoul National University Hospital 1 trial
Innovent Biologics Technology Limited (Shanghai R&D Center) 1 trial

Recruiting Clinical Trials

NCT07089875 Phase 3
Recruiting
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Enrollment
500 pts
Location
United States, Polan...
Sponsor
Crystalys Therapeutics
View Trial →
NCT04695028
Recruiting
CRYSTALILLE Cohort: Getting the Whole Picture of Crystal-related Arthropathies
Enrollment
1,000 pts
Location
France
Sponsor
Lille Catholic University
View Trial →
NCT05546593
Recruiting
Prevalence of Abnormalities in Ultrasonography of Joint and Tendons in Patients With Gout
Enrollment
200 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
View Trial →
NCT06622603 Phase 4
Recruiting
the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More
Enrollment
59 pts
Location
South Korea
Sponsor
Seoul National University Hosp...
View Trial →
NCT07414394 Phase 3
Recruiting
Tigulixostat (IBI128) vs Febuxostat in Gout
Enrollment
600 pts
Location
China
Sponsor
Innovent Biologics Technology ...
View Trial →

Related Conditions

chondrocalcinosis (1) hydroxyapatite (1) uric acid (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology